Vanberra Signal
SharePinPoint logo

SharePinPoint

Curated by Signal

Equity markets research platform offering analytics and stock tracking tools.

Overview

SharePinPoint operates in the fintech sector, focusing on equity markets research and analytics. The platform offers a range of products, including SharePoint webparts, stock tickers, portfolio trackers, and commodity price tickers, aimed at assisting investors and financial professionals in analyzing stock market trends and company performance. By aggregating data from various global stock exchanges and utilizing advanced analytics, SharePinPoint facilitates informed investment decisions. The platform includes customizable features and visualization tools to improve the accessibility of complex data, catering to a diverse client base across multiple continents. SharePinPoint's mission highlights the importance of simplicity and responsive support for users navigating equity markets.

Key facts

Founded
2017
Headquarters
Tallinn, Estonia

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Investment Technology companies
  • Equity markets research platform offering stock picking recommendations to investors.

    Investment Technology
  • Equity markets research platform offering stock screening and insights.

    Investment TechnologySydney, Australia
  • Equity markets research platform delivering real-time data and analytics.

    Investment Technology
+ 241 more similar companies on Signal

About SharePinPoint

What does SharePinPoint do?

SharePinPoint operates in the fintech sector, focusing on equity markets research and analytics.

Where is SharePinPoint headquartered?

SharePinPoint is headquartered in Tallinn, Estonia.

When was SharePinPoint founded?

SharePinPoint was founded in 2017.

Which sector is SharePinPoint in?

SharePinPoint operates in Investment Technology, part of Financial Technology.

Who are SharePinPoint's competitors?

Companies similar to SharePinPoint include Econvestor, EquiShark, and Finaza.